Krebs Biochemicals & Industries has informed that it enclosed copies of the Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2026 approved in the Board Meeting held on October 29, 2026 and published on October 30, 2026 in Business Standard (English) and Prajasakti (Telugu).
The above information is a part of company’s filings submitted to BSE.